Jove
Visualize
Contact Us

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective Human Trypsin Inhibitors from Cyanobacteria.

Journal of applied microbiology·2026
Same author

<i>Trichomonas vaginalis</i> PPi-dependent phosphofructokinase structures reveal a non-canonical nucleotide binding site.

bioRxiv : the preprint server for biology·2026
Same author

Matrix Stiffness Directs Stemness Signatures in Breast Cancer.

Advanced healthcare materials·2026
Same author

GBP1 recruitment to actin-rich pedestals of extracellular Gram-negative bacteria promotes pyroptosis.

The EMBO journal·2026
Same author

Structure-guided design of broad-spectrum inhibitors of coronaviral proteases embodying a 1,3,2-oxazaphospholidin-3-one scaffold as a versatile design element.

European journal of medicinal chemistry·2026
Same author

Ex vivo drug screening and clustering of bladder cancers for pre-clinical treatment prediction.

Communications medicine·2026
Same journal

Cephalotaxinone enzymes reveal a whole plant model for homoharringtonine biosynthesis.

Nature chemical biology·2026
Same journal

AI decodes protein-ligand binding.

Nature chemical biology·2026
Same journal

Cryo-EM sheds light on the mechanism of human telomerase inhibition by BIBR1532.

Nature chemical biology·2026
Same journal

Artificial metalloenzymes in complex biological environments.

Nature chemical biology·2026
Same journal

Allosteric disordering of eIF2B regulates the integrated stress response.

Nature chemical biology·2026
Same journal

A tail of two ligases.

Nature chemical biology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Nov 9, 2025

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9
08:14

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9

Published on: August 28, 2018

8.3K

Substrate-biased activity-based probes identify proteases that cleave receptor CDCP1.

Thomas Kryza1, Tashbib Khan1, Scott Lovell2,3

  • 1Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia.

Nature Chemical Biology
|April 16, 2021
PubMed
Summary
This summary is machine-generated.

CUB domain-containing protein 1 (CDCP1) is a cancer target. New probes identified urokinase (uPA) as a key enzyme that cleaves CDCP1, promoting cancer metastasis. Targeting this cleavage may disrupt cancer progression.

More Related Videos

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

10.5K
The Determination of Protease Specificity in Mouse Tissue Extracts by MALDI-TOF Mass Spectrometry: Manipulating PH to Cause Specificity Changes
09:47

The Determination of Protease Specificity in Mouse Tissue Extracts by MALDI-TOF Mass Spectrometry: Manipulating PH to Cause Specificity Changes

Published on: May 25, 2018

7.0K

Related Experiment Videos

Last Updated: Nov 9, 2025

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9
08:14

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9

Published on: August 28, 2018

8.3K
High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

10.5K
The Determination of Protease Specificity in Mouse Tissue Extracts by MALDI-TOF Mass Spectrometry: Manipulating PH to Cause Specificity Changes
09:47

The Determination of Protease Specificity in Mouse Tissue Extracts by MALDI-TOF Mass Spectrometry: Manipulating PH to Cause Specificity Changes

Published on: May 25, 2018

7.0K

Area of Science:

  • Oncology
  • Proteomics
  • Molecular Biology

Background:

  • CUB domain-containing protein 1 (CDCP1) is an oncogenic transmembrane receptor implicated in cancer.
  • Proteolytic cleavage of CDCP1 promotes cancer metastasis through poorly understood mechanisms.

Purpose of the Study:

  • To rapidly identify proteases responsible for CDCP1 cleavage.
  • To investigate the role of CDCP1 proteolysis in cancer metastasis.

Main Methods:

  • Development and application of a substrate-biased activity-based probe (sbABP) for protease identification.
  • In vivo preclinical models to assess metastasis promotion by CDCP1 proteolysis.

Main Results:

  • Identified urokinase (uPA) as the master regulator of CDCP1 proteolysis.
  • Demonstrated that uPA directly cleaves CDCP1 and activates plasmin for further cleavage.
  • Coexpression of uPA and CDCP1 predicts poor disease outcome across multiple cancers.
  • uPA-mediated CDCP1 proteolysis was shown to promote metastasis in vivo.

Conclusions:

  • CDCP1 cleavage is a potential therapeutic target for cancer treatment.
  • sbABP technology is a valuable tool for identifying disease-relevant proteases.
  • uPA-mediated CDCP1 cleavage drives cancer metastasis.